Zaragoza, Spain

Aida Olivan-Viguera

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aida Olivan-Viguera. Retrieved from https://idiyas.com/inventor/aida-olivan-viguera

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aida Olivan-Viguera: Innovator in KCa3.1 Channel Activators

Introduction

Aida Olivan-Viguera is a prominent inventor based in Zaragoza, Spain. She has made significant contributions to the field of biochemistry, particularly in the development of selective activators for the intermediate conductance calcium-activated potassium channel KCa3.1. Her work has implications for therapeutic uses in both human and animal subjects.

Latest Patents

Aida holds a patent titled "Selective activators of the intermediate conductance CA2+activated K+ channel KCa3.1 and their methods of use." This patent focuses on benzoxazole and indole type KCa3.1 activators, as well as their therapeutic applications and use in the ex vivo preservation of organs or tissues. She has 1 patent to her name, showcasing her innovative approach to medical science.

Career Highlights

Aida is affiliated with the University of California, where she continues her research and development in the field of potassium channels. Her academic background and ongoing research contribute to advancements in medical therapies and organ preservation techniques.

Collaborations

Aida has collaborated with notable researchers, including Heike Wulff and Nichole Coleman. These partnerships enhance her research capabilities and broaden the impact of her work in the scientific community.

Conclusion

Aida Olivan-Viguera is a trailblazer in the field of biochemistry, with her innovative work on KCa3.1 channel activators paving the way for future medical advancements. Her contributions are vital to the ongoing research in therapeutic applications and organ preservation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…